Advent Pharma Ltd. (DSE: ADVENT)
Bangladesh
· Delayed Price · Currency is BDT 15.60
-0.20 (-1.27%)
At close: Jan 29, 2025
Advent Pharma Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 28, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2016 |
| Market Capitalization | 1,406 | 2,384 | 2,459 | 2,338 | 2,274 | 1,893 | Upgrade
|
| Market Cap Growth | -21.74% | -3.03% | 5.18% | 2.82% | 20.13% | -25.58% | Upgrade
|
| Enterprise Value | 1,478 | 2,456 | 2,530 | 2,392 | 2,285 | 1,887 | Upgrade
|
| Last Close Price | 15.10 | 25.44 | 26.00 | 24.50 | 23.65 | 19.69 | Upgrade
|
| PE Ratio | 21.11 | 28.39 | 24.93 | 23.97 | 20.02 | 16.17 | Upgrade
|
| PS Ratio | 2.69 | 4.17 | 4.41 | 4.41 | 4.51 | 3.54 | Upgrade
|
| PB Ratio | 0.95 | 1.62 | 1.76 | 1.78 | 1.84 | 1.69 | Upgrade
|
| P/TBV Ratio | 1.13 | 1.62 | 1.76 | 1.78 | 1.84 | 1.69 | Upgrade
|
| P/FCF Ratio | 86.26 | 182.32 | 958.68 | - | - | - | Upgrade
|
| P/OCF Ratio | 11.14 | 13.61 | 11.98 | 13.02 | 12.60 | 11.13 | Upgrade
|
| EV/Sales Ratio | 2.83 | 4.30 | 4.53 | 4.51 | 4.54 | 3.53 | Upgrade
|
| EV/EBITDA Ratio | 7.96 | 11.83 | 13.05 | 13.66 | 13.09 | 10.01 | Upgrade
|
| EV/EBIT Ratio | 12.36 | 17.34 | 18.69 | 17.93 | 16.75 | 12.14 | Upgrade
|
| EV/FCF Ratio | 90.67 | 187.80 | 986.61 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | Upgrade
|
| Debt / EBITDA Ratio | 0.41 | 0.37 | 0.37 | 0.36 | 0.34 | 0.26 | Upgrade
|
| Debt / FCF Ratio | 4.65 | 5.81 | 27.91 | - | - | - | Upgrade
|
| Asset Turnover | 0.28 | 0.31 | 0.33 | 0.34 | 0.35 | 0.41 | Upgrade
|
| Inventory Turnover | 4.33 | 4.68 | 4.16 | 3.96 | 4.02 | 4.43 | Upgrade
|
| Quick Ratio | 0.89 | 0.78 | 0.62 | 0.71 | 1.03 | 1.24 | Upgrade
|
| Current Ratio | 1.41 | 1.28 | 1.15 | 1.38 | 1.72 | 2.01 | Upgrade
|
| Return on Equity (ROE) | 4.57% | 5.86% | 7.27% | 7.66% | 9.65% | 10.94% | Upgrade
|
| Return on Assets (ROA) | 4.04% | 4.86% | 4.93% | 5.27% | 5.90% | 7.53% | Upgrade
|
| Return on Capital (ROIC) | 4.87% | 5.87% | 5.94% | 6.24% | 6.92% | 8.74% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.09% | 8.49% | 8.56% | 9.05% | 9.97% | 12.54% | Upgrade
|
| Earnings Yield | 4.74% | 3.52% | 4.01% | 4.17% | 5.00% | 6.19% | Upgrade
|
| FCF Yield | 1.16% | 0.55% | 0.10% | -0.49% | -0.16% | -2.24% | Upgrade
|
| Dividend Yield | 0.64% | 0.39% | 0.77% | 0.82% | 0.83% | - | Upgrade
|
| Payout Ratio | 10.64% | 9.76% | 8.93% | 22.79% | 7.11% | 7.44% | Upgrade
|
| Total Shareholder Return | 0.64% | 0.39% | 0.77% | 0.82% | 0.83% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.